Bone Biologics Corporation Share Price & Technical Analysis
BBLG · $1.26 (-0.79%)
Healthcare / Biotechnology
$1.26
-0.79%
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as…
Price chart
Seasonality
Jun has 0 positive and 4 negative years (last 5 years shown)
0% return in Jun, -44% avg return in past 3 year Jun month.
-10% return in 2026, -126% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 7% | -25% | 0% | 8% | 0% | 0% | – | – | – | – | – | – | -10% |
| 25 | 20% | -17% | -8% | -18% | 29% | -31% | -28% | -21% | 33% | -25% | -29% | 0% | -95% |
| 24 | -19% | -31% | -26% | -28% | 5% | -27% | 71% | -62% | 54% | -36% | -11% | -25% | -134% |
| 23 | 23% | 1% | -16% | 6% | -31% | -75% | -10% | -46% | 7% | -25% | -20% | 38% | -149% |
| 22 | -39% | -13% | 53% | -16% | -29% | -10% | 7% | 0% | -32% | -55% | -33% | -28% | -197% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Neutral
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$2.28M
P/E ratio
—
52W high
$6.75
52W low
$1.05
Volume
8,231
Beta
0.53
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Bone Biologics Corporation share price today?
- Bone Biologics Corporation (BBLG) last traded around $1.26 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BBLG have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BBLG. Download the app for real-time alerts.
- How can I analyze Bone Biologics Corporation stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.